VetMed Therapeutics

VetMed Therapeutics is a private U.S. veterinary therapeutics company focused on developing drug interventions for musculoskeletal diseases in horses and potentially other animal species. The company has described its lead product, Equinox-PT, as a botulinum toxin-based therapy in development for laminitis, a serious and potentially fatal equine disease. Publicly available information suggests the business is an early-stage, single-asset animal health company rather than a diversified human biopharma company. Corporate records indicate the company is organized as VetMed Therapeutics, Inc. and has operated from Gulf Breeze, Florida.